THE TGF-β PATHWAY: A POTENTIAL MEDIATOR OF MEDULLOBLASTOMA PROGRESSION

被引：0
|
作者：
Aref, Donya [1 ]
Perry, Arie [2 ]
Taylor, Michael [1 ]
Eberhardt, Charles [3 ]
Olson, James [4 ]
Moffatt, Connor [1 ]
Croul, Sidney [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] UCSF, San Francisco, CA USA
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Univ Washington, Seattle, WA 98195 USA
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [31] In silico identification of potential therapeutic targets in the TGF-β signal transduction pathway
    Nicklas, Daniel
    Saiz, Leonor
    MOLECULAR BIOSYSTEMS, 2014, 10 (03) : 537 - 548
  • [32] TGF-β Signaling in Progression of Oral Cancer
    Guo, Yuanyuan
    Xu, Tiansong
    Chai, Yujuan
    Chen, Feng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [33] Role of TGF-β in the progression of renal fibrosis
    Tamaki, K
    Okuda, S
    RENAL FIBROSIS, 2003, 139 : 44 - 65
  • [34] PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway
    Long Fang
    Baolong Wang
    Zengkun Yang
    Tingbao Zhao
    Wei Hao
    Scientific Reports, 13
  • [35] TMEM100 Modulates TGF-β Signaling Pathway to Inhibit Colorectal Cancer Progression
    Li, Huixia
    Cheng, Chuan
    You, Weibo
    Zheng, Jiujian
    Xu, Jie
    Gao, Peng
    Wang, Jianping
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [36] PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway
    Fang, Long
    Wang, Baolong
    Yang, Zengkun
    Zhao, Tingbao
    Hao, Wei
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [37] TGF-β and αvβ6 Integrin Act in a Common Pathway to Suppress Pancreatic Cancer Progression
    Hezel, Aram F.
    Deshpande, Vikram
    Zimmerman, Stephanie M.
    Contino, Gianmarco
    Alagesan, Brinda
    O'Dell, Michael R.
    Rivera, Lee B.
    Harper, Jay
    Lonning, Scott
    Brekken, Rolf A.
    Bardeesy, Nabeel
    CANCER RESEARCH, 2012, 72 (18) : 4840 - 4845
  • [38] TGF-β is a key mediator of NK cell dysfunction in gliolastoma
    Shaim, Hila
    Alsuliman, Abdullah
    Gabrusiewicz, Konrad
    Wei, Jun
    Yu, John
    Basar, Rafet
    Daher, May
    Kerbauy, Lucila
    Mendt, Mayela
    Muftuoglu, Muharrem
    Li, Li
    Liu, Enli
    Imahashi, Nobuhiko
    Ang, Sonny
    Gi, Young
    Banerjee, Pinaki
    Marin, David
    Champlin, Richard
    Shpall, Elizabeth
    Heimberger, Amy
    Rezvani, Katayoun
    CANCER RESEARCH, 2017, 77
  • [39] Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer
    Khoshakhlagh, Mandieh
    Soleimani, Atena
    Binabaj, Maryam Moradi
    Avan, Amir
    Ferns, Gordon A.
    Khazaei, Majid
    Hassanian, Seyed Mandi
    BIOCHEMICAL PHARMACOLOGY, 2019, 164 : 17 - 22
  • [40] Ets1 is an effector of TGF-β pathway and an antagonist of profibrotic effects of TGF-β
    Czuwara-Ladykowska, J
    Sementchenko, V
    Watson, DK
    Trojanowska, M
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 198A - 198A
12345